Physician profile
Harsimran S Singh
NPI 1841224342
$9,727.76
in general payments reported to CMS, 2019-2025
16 companies · $956 in 2025
The $956 reported for 2025 was more than what 80% of Adult Congenital Heart Disease providers received nationally (typical 2025 total: $272).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,690 · 2021: $984 · 2022: $814 · 2023: $2,864 · 2024: $2,419 · 2025: $956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,019 · Travel and Lodging: $2,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,018.88 |
| Travel and Lodging | $2,220.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,175.78 | 2021-2025 | Harmony, Abre, Symplicity G3 |
| Abbott Laboratories | $1,969.39 | 2019-2025 | Amplatzer, Mitraclip, Amplatzer Talisman |
| Medtronic Vascular, INC. | $1,530.22 | 2019 | |
| Edwards Lifesciences Corporation | $1,426.05 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Spectrawave, INC | $378.33 | 2024-2025 | Hypervue Imaging System, Starlight Imaging Catheter |
| Philips North America LLC | $267.91 | 2025 | Coronary Other |
| Shockwave Medical, INC | $200.09 | 2022 | |
| Boston Scientific Corporation | $173.65 | 2025 | Avvigo Guidance System |
| Abiomed | $153.96 | 2022 | |
| Endologix LLC | $150.00 | 2025 | Endocross Device, Torus Stent Graft System |
| Heartflow, INC. | $149.77 | 2024 | |
| Sumitomo Pharma America, INC. | $69.28 | 2023 | Gemtesa |
| Janssen Pharmaceuticals, INC | $30.79 | 2025 | Spravato |
| Amgen INC. | $24.88 | 2023 | Repatha |
| Chiesi USA, INC. | $14.52 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.14 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harsimran Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.